Ignite Creation Date:
2025-12-24 @ 5:46 PM
Ignite Modification Date:
2025-12-24 @ 5:46 PM
Study NCT ID:
NCT04098068
Status:
COMPLETED
Last Update Posted:
2025-03-30
First Post:
2019-09-19
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Study of MK-3475 (Pembrolizumab) in Patients With Microsatellite Unstable (MSI) Tumors (Cohort D)
Sponsor:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-01-25
Start Date Type:
ACTUAL
Primary Completion Date:
2022-05-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-02-05
Completion Date Type:
ACTUAL
First Submit Date:
2019-09-19
First Submit QC Date:
None
Study First Post Date:
2019-09-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-03-30
Results First Submit QC Date:
None
Results First Post Date:
2023-05-19
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-03-13
Last Update Post Date:
2025-03-30
Last Update Post Date Type:
ACTUAL